Eren Erken

2.3k total citations
60 papers, 706 citations indexed

About

Eren Erken is a scholar working on Molecular Biology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Eren Erken has authored 60 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Rheumatology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Eren Erken's work include Inflammasome and immune disorders (15 papers), Systemic Sclerosis and Related Diseases (9 papers) and Vasculitis and related conditions (7 papers). Eren Erken is often cited by papers focused on Inflammasome and immune disorders (15 papers), Systemic Sclerosis and Related Diseases (9 papers) and Vasculitis and related conditions (7 papers). Eren Erken collaborates with scholars based in Türkiye, United States and Germany. Eren Erken's co-authors include Hüseyin Özer, Ramazan Güneşaçar, Bozkurt Gülek, Süleyman Özbek, Mehmet Soy, Didem Arslan, Tunay Sarpel, Z. Nazan Alparslan, Merih Soylu and Ertuğrul Erken and has published in prestigious journals such as SHILAP Revista de lepidopterología, Spine and Annals of the Rheumatic Diseases.

In The Last Decade

Eren Erken

56 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eren Erken Türkiye 16 259 221 195 133 120 60 706
Jasmin Kümmerle‐Deschner Germany 13 206 0.8× 196 0.9× 194 1.0× 82 0.6× 61 0.5× 35 627
Soma Jyonouchi United States 18 185 0.7× 114 0.5× 412 2.1× 177 1.3× 229 1.9× 41 969
Elisa Benetti Italy 21 350 1.4× 122 0.6× 88 0.5× 89 0.7× 196 1.6× 63 1.2k
Toshimasa Shimizu Japan 17 249 1.0× 390 1.8× 321 1.6× 149 1.1× 82 0.7× 90 983
Murat Turgay Türkiye 13 102 0.4× 237 1.1× 120 0.6× 61 0.5× 120 1.0× 74 581
Daniel G. Arkfeld United States 15 111 0.4× 302 1.4× 264 1.4× 86 0.6× 66 0.6× 35 868
Adil Muhib Sâmara Brazil 17 78 0.3× 459 2.1× 230 1.2× 88 0.7× 217 1.8× 48 791
Nancy Solowski United States 7 113 0.4× 205 0.9× 261 1.3× 88 0.7× 39 0.3× 11 699
Yair Molad Israel 15 84 0.3× 368 1.7× 229 1.2× 51 0.4× 57 0.5× 29 692
Syuichi Koarada Japan 21 141 0.5× 328 1.5× 596 3.1× 182 1.4× 73 0.6× 56 1.1k

Countries citing papers authored by Eren Erken

Since Specialization
Citations

This map shows the geographic impact of Eren Erken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eren Erken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eren Erken more than expected).

Fields of papers citing papers by Eren Erken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eren Erken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eren Erken. The network helps show where Eren Erken may publish in the future.

Co-authorship network of co-authors of Eren Erken

This figure shows the co-authorship network connecting the top 25 collaborators of Eren Erken. A scholar is included among the top collaborators of Eren Erken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eren Erken. Eren Erken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yıldız, Fatih, Bülent Kaya, & Eren Erken. (2023). Metformin-induced systemic vasculitis: A rare case report and literature review. 15(3). 162–166.
2.
Yıldız, Fatih, et al.. (2023). Mevalonate kinase gene polymorphisms in ankylosing spondylitis patients: A cross-sectional study. Archives of Rheumatology. 38(2). 238–248. 1 indexed citations
3.
Tuncer, I, et al.. (2023). CD39 expression on immune cells predicts methotrexate response in rheumatoid arthritis patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 53(5). 1075–1083. 1 indexed citations
4.
Sarpel, Tunay, et al.. (2021). The Efficacy of a Home-Based, Self-Administered Hand Exercise Program for Patients With Systemic Sclerosis. JCR Journal of Clinical Rheumatology. 28(2). e422–e429. 9 indexed citations
5.
Gülek, Bozkurt, et al.. (2021). Arterial evaluation of systemic sclerosis patients with Doppler ultrasound: What did we find?. International Journal of Rheumatic Diseases. 24(7). 954–962. 2 indexed citations
6.
Çeti̇ner, Sali̇h, Filiz Kibar, Eren Erken, et al.. (2019). Importance of 14-3-3eta, anti-CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(5). 1498–1502. 13 indexed citations
7.
Sarpel, Tunay, et al.. (2018). Neuropathic pain: is it an underestimated symptom in systemic sclerosis?. Clinical Rheumatology. 37(7). 1845–1851. 8 indexed citations
8.
Çetin, Gözde Yıldırım, Timuçin Kaşifoğlu, Eren Erken, et al.. (2018). Exon 2: Is it the good police in familial mediterranean fever?. SHILAP Revista de lepidopterología. 6(1). 34–37. 11 indexed citations
9.
Erken, Ertuğrul, et al.. (2017). AİLESEL AKDENİZ ATEŞİ (AAA) HASTALARINDA MANNOZ BAĞLAYICI LEKTİN (MBL) GEN POLİMORFİZMLERİ VE KLİNİK ÖZELLİKLERLE İLİŞKİSİ. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 80(4). 125–130. 1 indexed citations
10.
Omma, Ahmet, Burak Erer, Ömer Karadağ, et al.. (2017). Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort.. PubMed. 35 Suppl 103(1). 77–82. 14 indexed citations
11.
Erken, Eren & Ertuğrul Erken. (2017). Cardiac disease in familial Mediterranean fever. Rheumatology International. 38(1). 51–58. 20 indexed citations
12.
Bozkurt, Abdi, Didem Arslantaş, Onur Kaypaklı, et al.. (2016). Is cystatin C an evaluative marker for right heart functions in systemic sclerosis?. International Journal of Cardiology. 221. 478–483. 3 indexed citations
13.
Erken, Eren, Çiğdem Köroğlu, Fatih Yıldız, et al.. (2014). A novel recessive 15-hydroxyprostaglandin dehydrogenase mutation in a family with primary hypertrophic osteoarthropathy. Modern Rheumatology. 25(2). 315–321. 17 indexed citations
14.
Arslan, Didem, et al.. (2012). Different clinical presentation of the hyperimmunoglobulin D syndrome (HIDS) (four cases from Turkey). Clinical Rheumatology. 31(5). 889–893. 9 indexed citations
15.
Deniz, Ali, et al.. (2012). Familial Takayasu arteritis in a mother and daughter: a report of two cases. Herz. 38(1). 93–96.
16.
Güneşaçar, Ramazan, et al.. (2007). Analysis of CD28 and CTLA‐4 gene polymorphisms in Turkish patients with Behcet's disease. International Journal of Immunogenetics. 34(1). 45–49. 53 indexed citations
17.
Erken, Eren, et al.. (2006). Evaluation of the turkish version of the bath ankylosing Spondylitis Patient Global Score (BAS-G). Clinical Rheumatology. 25(2). 136–139. 4 indexed citations
19.
Sarpel, Tunay, et al.. (2005). Evaluation of the Turkish version of the Dougados functional index in ankylosing spondylitis. Rheumatology International. 25(5). 368–372. 2 indexed citations
20.
Skare, James, Hasan Yazıcı, Eren Erken, et al.. (1990). Homozygosity for the met30 transthyretin gene in a Turkish kindred with familial amyloidotic polyneuropathy. Human Genetics. 86(1). 89–90. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026